- Description
- Specifications
Catalog #: IHA-001
Description:
Recombinant Full-Length H1N1 New Caledonia/20/99 is glycosylated with N-linked sugars, produced using baculovirus vectors in insect cells and its Mw is approximately 72 kDa.
The insect cells infected with A9440.1a recombinant baculovirus expressing recombinant H1N1 A/New Caledonia/20/99.
H1N1 New Caledonia shows 90% similarity to the A/PR/8/34 amino acid sequence.
The accession number is DQ508857.
Source:
Baculovirus Insect Cells.
Purity:
Greater than 90.0% as determined by:
Analysis by SDS-PAGE, HA1 and HA2 bands are observed using SDS-PAGE under reducing conditions.
Formulation:
The Recombinant H1N1 A/New Caledonia/20/99 solution 10mM Sodium phosphate, pH 7.2, 150mM NaCl.
Stability:
H1N1 A/New Caledonia/20/99 Recombinant should be stored at 4C.
Activity:
Western-Blot 0.1 µg -1 µg per strip, ELISA 1 µg/Well.
Physical Appearance:
Sterile Filtered colorless solution.
Usage:
Denovo Biotechnology's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
References:
Title: Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection
Publication: The Rockefeller University Press, doi: 10.1084/jem.2
1352
© 2011 Wrammert et al.
Link:http://jem.rupress.org/content/early/2011/01/06/jem.2
1352.full
